Overweight and obesity in mortality of patient with heart failure with preserved ejection fraction
Keywords:
heart failure; fraction of preserved ejection; predictAbstract
Introduction: The heart failure with fraction of preserved ejection associates to a high morbilidad and mortality. It is a clinical illness and very heterogeneous physiopathology that frequently associates to the overweight and the obesity. Objective: To evaluate the relationship between the overweight and the obesity with the mortality in patient with heart failure with fraction of preserved ejection. Methods: He/she was carried out a prospective observational analytic study of cohort in 101 patients assisted in the consultation of heart failure of the Hospital Ameijeiras. Was considered the probability of being free of death, by means of the employment of the method of Kaplan Meier. To evaluate the association among clinical variables and of presage in relation to the mortality the relative risk was determined. To evaluate the value presage of the overweight and the obesity in relation to the mortality, the pattern of regression of Cox was used.
Results: The patient overweight and obese, they showed higher survival than the normal-weigth group, Log Rank p = 0,045. The factors presage that prevailed in both groups went the biggest age to 70 years (80 % and 57,1), and to present two or more revenues (60 % and 71,4). In the pattern of regression of Cox the group of the overweights, an adjusted OR 0,259 showed; IC: 0,090 - 0,748 in relation to the mortality.
Conclusions: To present overweight showed to be a factor favorable presage to diminish the mortality, independently of the presence of other factors related with the presage.
Downloads
References
1. Chao C, Hilera A, Castellanos D. Obesidad en la mortalidad de pacientes con insuficiencia cardíaca y fracción de eyección reducida. Rev Cub Med. 2022 [acceso 12/12/2023];61(2). Disponible en: https://www.medigraphic.com/pdfs/revcubmed/cm-2022/cm222j.pdf
2. Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud 2024. La Habana: MINSAP; 2025 [acceso 06/12/2025]. Disponible en: https://files.sl.cu/dne/files/2024/04/anuario-electronico-espa%c3%b1ol-2024.pdf
3. Endalifer ML, Diress G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. Journal of Obesity. 2020:6134362. DOI: https://doi.org/10.55204/trc.v4i1.e366
4. Endalifer ML, Diress G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. Journal of Obesity. 2020:6134362. DOI: https://doi.org/10.55204/trc.v4i1.e366
5. Donini LM, Pinto A, Giusti AM, Lenzi A and Poggiogalle E. Obesity or BMI Paradox? Beneath the Tip of the Iceberg. Front. Nutr. 2020;7:53. DOI: https://doi.org/10.3389/fnut.2020.00053.
6. Piñar Sancho G, Céspedes Prado D. Insuficiencia cardíaca en el adulto mayor. Rev Med Sin. 2020 [acceso 13/10/ 025]; (9): 67. Disponible en https://revistamedicasinergia.com/index.php/rms/article/view/567/999
7. Rillig M, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation. 2021 [acceso 02/10/2025]14;144(11):845-58. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8456351/.
8. Ruiz A, Serrano A, Escobar C, Arranz E, Turégano M, Pallarés V. Heart failure prevalence rates and its association with other cardiovascular diseases and chronic kidney disease: SIMETAP-HF Study. J Clin Med. 2023 [acceso 02/10/2025];26;12(15):4924. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10419820/.
9. Köseoğlu FD, Özlek B. Anemia and iron deficiency predict all - cause mortality in patients with heart failure and preserved ejection fraction: 6 - year follow - up study. 2024 [acceso 10/10/2025];14(2):209. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10814779/
10. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para la investigación médica con participantes humanos. JAMA. 2025;333;(1):71-4. DOI: https://doi.org/10.1001/jama.2024.21972
11. Golla MSG, Shams P. Insuficiencia con fracción de eyección preservada (ICFEp) [Actualizado el 19 de marzo de 2024]. En: StatPearls. Treasure Island (FL): StatPearls Publishing; enero de 2025. [acceso 10/10/2025]. Disponible en: https://www-ncbi-nlm-nih-gov.translate.goog/books/NBK599960.
12. Puig T, Ferrero - Gregori A, Roig A, Vázquez R, González - Juanatey JR, Pascual - Figal D, et al. Valor pronóstico del índice de masa corporal y el perímetro de cintura en los pacientes con insuficiencia cardíaca crónica (Registro Español REDINSCOR). Rev Esp Cardiol. 2014 [acceso 10/10/2025];67:101-6. Disponible en: https://www.revespcardiol.org/es-valor-pronostico-del-indice-de-masa-corp-articulo-S0300893213003692
13. Savarese G, Schiattarella G, Lindberg F, Anker MS, Bayes - Genis A, Back M, et al. Insuficiencia y obesidad: Enfoques traslacionales y perspectivas terapéuticas. Declaración científica de la Asociación de Insuficiencia de la ESC. Primera publicación: 6 de mayo de 2025. DOI: https://doi.org/10.1002/ejhf.3676
14. Powell - Wiley T, Poirier P, Burke LE, Després JP, Gordon - Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: A scientific statement for the American Heart Association. Circulation. 2021;143(21):e984-e1010. DOI: https://doi.org/10.1161/CIR.0000000000000973
15. Fink T, Sciacca V, Kirchhof P, Sommer P. Contemporary trends of atrial fibrillation management in heart failure patients: Do we practice what we preach? Eur J Heart Fail. 2025;27(2): 249-51. DOI: http://doi.org/10.1002/ejhf
16. Insuficiencia Cardíaca. Necesidades urgentes y garantías ante un problema sanitario de primer orden en España. 2025 [acceso 11/10/2025]. Disponible en: https://www.semg.es/images/2021/Noticias/objetivo_2025_insf.cardíaca.pdf.
17. Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez - Jiménez F, et al. Meta - analysis of the relation of body mass index to all - cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428-34. DOI: https://doi.org/10.1016/j.amjcard.2015.02.024
18. Nguyen HTT, Ha TTT, Tran HB, Nguyen DV, Pham HM, Tran PM, et al. Relationship between BMI and prognosis of chronic heart failure outpatients in Vietnam: a single - center study. Front Nutr.2023;10:1251601. DOI: https://doi.org/10.3389/fnut.2023.1251601
19. Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, et al. Metaanálisis del Grupo Global de Insuficiencia Cardíaca Crónica (MAGGIC). La paradoja de la obesidad en pacientes con insuficiencia cardíaca con fracción de eyección conservada versus reducida: Un metaanálisis de datos de pacientes individuales. Int J Obes (Londres) 2014;38:1110-14. DOI: https://doi.org/10.1038/ijo.2013.203
20. Tsujimoto T, Kajio H. La obesidad abdominal se asocia con un mayor riesgo de mortalidad por cualquier causa en pacientes con ICFEp. J Am Coll Cardiol 2017;70:2739-2749. DOI: https://doi.org/10.1016/j.jacc.2017.09.1111
21. Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, et al. Índice cintura - cadera y mortalidad en insuficiencia cardíaca. Eur J Heart Fail 2018;20:1269-77. DOI: https://doi.org/10.1002/ejhf.1244
22. Chandramouli C, Tay WT, Bamadhaj NS, Tromp J, Teng THK, Yap JJL, et al. Investigadores de ASIAN – HF. Asociación de la obesidad con resultados de insuficiencia cardíaca en 11 regiones asiáticas: Un estudio de cohorte. PLoS Med 2019;16:e1002916. DOI: https://doi.org/10.1371/ljournal.pmed.1002916
23. Piepoli MF, Corrá U, Veglia F, Bonomi A, Salvioni , Cattadori G, et al. MECKI Score Research Group. La tolerancia al ejercicio puede explicar la paradoja de la obesidad en pacientes con insuficiencia cardíaca sistólica: Datos del MECKI Score Research Group. Eur J Heart Fail 2016;18:545-553. DOI: https://doi.org/10.1002/ejhf534
24. Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, et al. La ciencia del manejo de la obesidad: una declaración científica de la Endocrine Society. Endocr Rev. 2018;39:79-132. DOI: https://doi.org/10.1210/er.2017-00253
25. Peck KH, Dulay MS, Hammed S, Rosano G, Tan T, Dar O. Pérdida de peso intencional en pacientes con sobrepeso y obesidad con insuficiencia cardíaca.: Una revisión sistemática. Eur J Heart Fail 2024;26:1907-1930. DOI: https://doi.org/10.1002/ejhf.3270
26. Vest AR, Chan M, Deswal A, Givertz MM, Lekavich C, Lennie T, et al. Nutrición, obesidad y caquexia en pacientes con insuficiencia cardíaca: Una declaración de consenso del Comité de Declaraciones Científicas de la Sociedad Americana de Insuficiencia Cardíaca. J Car Fail 2019;25:380-400. DOI: https://doi.org/10.1016/j.cardfail.2019.03.007.
27. Beck-da-Silva L, Higginson L, Fraser M, Williams K, Haddad H. Efecto del orlistat en pacientes obesos con insuficiencia cardíaca: Un estudio piloto. Congest Heart Fail 2005;11:118-23. DOI: https://doi.org/10.101111/j.1527-5299.2005.03827
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Caridad Chao Pereira, Fabiola Gutiérrez García, Dorian Castellanos Almaguer, Ángela Rosa Gutiérrez Rojas, Marianne Nievas Sánchez, Snayder José Goelker Pérez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Cuban Journal of Medicine protects the author's patrimonial rights. However, it is licensed under a Creative Commons Licensehttps://creativecommons.org/licenses/by-nc/4.0/deed.es_ES which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is duly cited. The author always retains his moral rights.
You are free to:
- Share - copy and redistribute the material in any medium or format.
- Adapt - remix, transform and build upon the material
- The license cannot revoke these freedoms as long as you follow the terms of the license.
Under the following terms:
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is supported by the licensor.
- Non-Commercial Purpose- You may not make use of the material for commercial purposes.
- No Additional Restrictions - You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
